EU Says J&J, Novartis Pay-For-Delay Breached Antitrust Laws

Law360, New York (January 31, 2013, 1:06 PM EST) -- European antitrust regulators said Thursday they believed drugmakers Johnson & Johnson and Novartis AG violated European competition law by inking an agreement to delay the launch of cheaper generic drugs in the Netherlands.

After more than a year of investigation, the European Commission sent formal objections that accused Dutch J&J unit Janssen-Cilag of paying off Novartis subsidiary Sandoz to not launch a generic version of the painkiller fentanyl.

The so-called pay-for-delay deal eliminated any competition for J&J's fentanyl from July 2005 until December 2006, keeping the...
To view the full article, register now.